Delivery Order SPE2DB22D3501-SPE2DB25FXB77
Award Date 8/28/25
Potential Completion Date 8/29/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $18,608.38 delivery order to AmerisourceBergen Drug Corp for 500 mg Dalvance vials, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $3,760.90 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic pharmaceutical product. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child delivery order, this award falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,284.07 to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 15, 2025. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA Troop Support Medical. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,377.68 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, an antibiotic medication used to treat bacterial skin infections. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive, non-set-aside purchase. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $2,242.43 delivery order to AmerisourceBergen Drug Corp for 500 mg Dalvance vials, with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under the company's broader indefinite delivery contract vehicle with DLA. The work is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,090.15 firm fixed-price delivery order is for the supply of 4,567,894,030 units of DALVANCE 500 MG vials. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $8,929.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of DALVANCE 500 MG VIALS, a pharmaceutical product, with a completion date of June 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DALVANCE 500 MG VIALS. The $5,377.68 firm fixed price contract has an ultimate completion date of April 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DALVANCE 500 mg vials valued at $9,785.46 under a firm fixed price contract type. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, and no set-aside designation was applied. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a pediatric/neonatal antimicrobial supply supporting...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.56 firm fixed-price contract is for the delivery of 4,567,865,750 units of the drug DALVANCE 500 MG VIALS. The contract has an ultimate completion date of April 11, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...